PMC:7784786 / 9489-9664 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"307","span":{"begin":85,"end":89},"obj":"Gene"},{"id":"329","span":{"begin":4,"end":14},"obj":"Chemical"}],"attributes":[{"id":"A307","pred":"tao:has_database_id","subj":"307","obj":"Gene:3569"},{"id":"A329","pred":"tao:has_database_id","subj":"329","obj":"MESH:C000597346"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"ore itolizumab administration and after 2, 4 and 7 days of the first administration. IL-6 was extremely high at baseline (623 pg/ml) and even though cytokine levels reduced ro"}